The prevalence of PAI-1 4G/5G polymorphism in women with fetal loss: First data for a Serbian population

V Đorđević, M Gvozdenov, I Pruner… - Journal of Medical …, 2014 - scindeks.ceon.rs
Background: Plasminogen activator inhibitor 1 (PAI-1) is an inhibitor of fibrinolysis. The PAI-
1 4G/5G polymorphism is associated with elevated plasma levels of PAI-1. Overexpression …
被引用次数：10 相关文章

THE PREVALENCE OF PAI-1 4G/5G POLYMORPHISM IN WOMEN WITH FETAL LOSS-FIRST DATA FOR A SERBIAN POPULATION/UČESTALOST POLIMORFIZMA …

V Đorđević, M Gvozdenov, I Pruner… - Journal of Medical …, 2014 - search.ebscohost.com
Background: Plasminogen activator inhibitor 1 (PAI-1) is an inhibitor of fibrinolysis. The PAI-
1 4G/5G polymorphism is associated with elevated plasma levels of PAI-1. Overexpression …

The prevalence of PAI-1 4G/5G polymorphism in women with fetal loss-first data for a Serbian population.

V Ðorđević, M Gvozdenov, I Pruner, M Kovač, B Tomić… - 2014 - cabidigitallibrary.org
Background: Plasminogen activator inhibitor 1 (PAI-1) is an inhibitor of fibrinolysis. The PAI-
1 4G/5G polymorphism is associated with elevated plasma levels of PAI-1. Over-expression …

The prevalence of PAI-1 4G/5G polymorphism in women with fetal loss-first data for a Serbian population.

V Ðorđević, M Gvozdenov, I Pruner, M Kovač… - Journal of Medical …, 2014 - cabdirect.org
Background: Plasminogen activator inhibitor 1 (PAI-1) is an inhibitor of fibrinolysis. The PAI-
1 4G/5G polymorphism is associated with elevated plasma levels of PAI-1. Over-expression …
[PDF] academia.edu

[PDF][PDF] THE PREVALENCE OF PAI-1 4G/5G POLYMORPHISM IN WOMEN WITH FETAL LOSS–FIRST DATA FOR A SERBIAN POPULATION

PPZAS POPULACIJU - J Med Biochem, 2014 - academia.edu
Background: Plasminogen activator inhibitor 1 (PAI-1) is an inhibitor of fibrinolysis. The PAI-
1 4G/5G polymorphism is associated with elevated plasma levels of PAI-1. Overexpression …

THE PREVALENCE OF PAI-1 4G/5G POLYMORPHISM IN WOMEN WITH FETAL LOSS-FIRST DATA FOR A SERBIAN POPULATION/UcESTALOST POLIMORFIZMA …

V Dordevic, M Gvozdenov, I Pruner… - Journal of Medical …, 2013 - search.proquest.com
Background: Plasminogen activator inhibitor 1 (PAI-1) is an inhibitor of fibrinolysis. The PAI-
1 4G/5G polymorphism is associated with elevated plasma levels of PAI-1. Over-expression …

The prevalence of PAI-1 4G/5G polymorphism in women with fetal loss: First data for a Serbian population

Đ Valentina, G Maja, P Iva, K Mirjana, T Branko… - 2014 - agris.fao.org
Background: Plasminogen activator inhibitor 1 (PAI-1) is an inhibitor of fibrinolysis. The PAI-
1 4G/5G polymorphism is associated with elevated plasma levels of PAI-1. Overexpression …
[PDF] dmbj.org.rs

[PDF][PDF] THE PREVALENCE OF PAI-1 4G/5G POLYMORPHISM IN WOMEN WITH FETAL LOSS–FIRST DATA FOR A SERBIAN POPULATION

PPZAS POPULACIJU - J Med Biochem, 2014 - dmbj.org.rs
Background: Plasminogen activator inhibitor 1 (PAI-1) is an inhibitor of fibrinolysis. The PAI-
1 4G/5G polymorphism is associated with elevated plasma levels of PAI-1. Overexpression …
[PDF] archive.org

[PDF][PDF] THE PREVALENCE OF PAI-1 4G/5G POLYMORPHISM IN WOMEN WITH FETAL LOSS–FIRST DATA FOR A SERBIAN POPULATION

PPZAS POPULACIJU - J Med Biochem, 2014 - scholar.archive.org
Background: Plasminogen activator inhibitor 1 (PAI-1) is an inhibitor of fibrinolysis. The PAI-
1 4G/5G polymorphism is associated with elevated plasma levels of PAI-1. Overexpression …
[PDF] researchgate.net

[PDF][PDF] THE PREVALENCE OF PAI-1 4G/5G POLYMORPHISM IN WOMEN WITH FETAL LOSS–FIRST DATA FOR A SERBIAN POPULATION

PPZAS POPULACIJU - J Med Biochem, 2014 - researchgate.net
Background: Plasminogen activator inhibitor 1 (PAI-1) is an inhibitor of fibrinolysis. The PAI-
1 4G/5G polymorphism is associated with elevated plasma levels of PAI-1. Overexpression …